NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $84,072 | -13.3% | 37,200 | +22.8% | 0.01% | -40.0% |
| Q3 2022 | $97,000 | -68.9% | 30,300 | -63.1% | 0.02% | -65.5% |
| Q2 2022 | $312,000 | +13.5% | 82,200 | +497.0% | 0.06% | -7.9% |
| Q1 2021 | $275,000 | -8.3% | 13,769 | -21.9% | 0.06% | -19.2% |
| Q4 2020 | $300,000 | -52.8% | 17,630 | +35.5% | 0.08% | -45.5% |
| Q2 2018 | $635,000 | -19.9% | 13,009 | +74.3% | 0.14% | -29.2% |
| Q1 2018 | $793,000 | -13.8% | 7,465 | -51.5% | 0.20% | +7.4% |
| Q4 2017 | $920,000 | +251.1% | 15,400 | +37.9% | 0.19% | +51.6% |
| Q1 2017 | $262,000 | -11.8% | 11,170 | -53.8% | 0.12% | +67.6% |
| Q4 2016 | $297,000 | – | 24,200 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |